Insilico Medicine CEO Alex Zhavoronkov to speak on longevity and AI in healthcare at Fortune Global Forum in Riyadh

Insilico Medicine·Oct 24

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Insilico Medicine's CEO, Alex Zhavoronkov, is set to speak at the Fortune Global Forum in Riyadh on the topic of longevity and AI in healthcare. The company is also involved in various initiatives related to longevity research and AI-driven drug discovery. Insilico Medicine and its CEO are being recognized for their work in this field, with the company announcing the establishment of a Longevity Board to accelerate aging research.

Full coverage

Insilico Medicine founder to highlight sustainable longevity at BIO Asia-Taiwan

News-Medical·Jul 11

Insilico Medicine founder and CEO Alex Zhavoronkov recognized in inaugural SCW75 for pioneering AI-driven drug discovery and longevity research

EurekAlert!·Jun 4

Insilico Medicine Announces Industry’s First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery

Insilico Medicine·Apr 21

Longevity biotech learned to speak pharma’s language. Now the field is maturing.

R&D World·May 20

Insilico Medicine’s CEO Dr. Alex Zhavoronkov recognized among global top one per cent for pharmacology and toxicology

EurekAlert!·Nov 18

View original report at Insilico Medicine ↗

Fetching the latest headlines…